NURS 6013 fiNal StUdy QUEStiONS aNd CORRECt dEtailEd
aNSWERS (VERifiEd aNSWERS) |alREady GRadEd
a+||BRaNd NEW
vitamin B12 deficiency can cause people to develop - aNSWER-nerve conduction problems or
nerve damage
goal of asthma treatment - aNSWER--relieve symptoms
-prevent acute attacks
- improve quality of life
treatment of mild persistent asthma, the common adverse effect and how to avoid - aNSWER--
low dose inhaled corticosteroids
-often cause thrush, rinse mouth after use
CAP abx therapy is based on: - aNSWER--setting patient is being treated in
-history of abx usage
-allergies
first line choice for CAP therapy for otherwise healthy patient without history of current abx use -
aNSWER-amoxicillin
treatment for drug resistant tuberculosis - aNSWER-at least 2 drugs that TB is susceptible to
(rifapentine-moxifloxacin)
which hormone therapy increases risk of MI in women - aNSWER-estrogen
, combined contraceptives should be avoided in what patient - aNSWER-patient with history of
clotting disorder
first line therapy in diabetes, hyperlipidemia, and obesity - aNSWER-lifestyle change
first like treatment for African American patients with HTN - aNSWER-calcium channel blockers
first line treatment for dermatophyte infections - aNSWER-topical antifungals
first line treatment for tine capitis - aNSWER-oral anti fungal (griseofulvin for 6-8 weeks)
(topical antifungals dont penetrate hair shaft to treat)
treatment for patient with a tinea infection with an allergy to -azole meds - aNSWER-terbinafine
impetigo infection type and first line therapy - aNSWER--bacterial infection
-bactroban (mupirocin)
-antifungal medications not effective
child presenting with multiple infections - aNSWER-treat with one medication that covers all
conditions to increase compliance
treatment for opioid induced constipation and its method of action - aNSWER-methylnaltrexone
has limited ability to cross blood brain barrier allowing the ability to antagonize peripheral μ-
opioid receptors- does not affect opioid effectiveness
first line treatment for patients with h.pylori - aNSWER-triple therapy
-PPI, clarithromycin, and amoxicillin for 14 days
glycogenesis - aNSWER-storing of excess glucose for body to use at a later time
aNSWERS (VERifiEd aNSWERS) |alREady GRadEd
a+||BRaNd NEW
vitamin B12 deficiency can cause people to develop - aNSWER-nerve conduction problems or
nerve damage
goal of asthma treatment - aNSWER--relieve symptoms
-prevent acute attacks
- improve quality of life
treatment of mild persistent asthma, the common adverse effect and how to avoid - aNSWER--
low dose inhaled corticosteroids
-often cause thrush, rinse mouth after use
CAP abx therapy is based on: - aNSWER--setting patient is being treated in
-history of abx usage
-allergies
first line choice for CAP therapy for otherwise healthy patient without history of current abx use -
aNSWER-amoxicillin
treatment for drug resistant tuberculosis - aNSWER-at least 2 drugs that TB is susceptible to
(rifapentine-moxifloxacin)
which hormone therapy increases risk of MI in women - aNSWER-estrogen
, combined contraceptives should be avoided in what patient - aNSWER-patient with history of
clotting disorder
first line therapy in diabetes, hyperlipidemia, and obesity - aNSWER-lifestyle change
first like treatment for African American patients with HTN - aNSWER-calcium channel blockers
first line treatment for dermatophyte infections - aNSWER-topical antifungals
first line treatment for tine capitis - aNSWER-oral anti fungal (griseofulvin for 6-8 weeks)
(topical antifungals dont penetrate hair shaft to treat)
treatment for patient with a tinea infection with an allergy to -azole meds - aNSWER-terbinafine
impetigo infection type and first line therapy - aNSWER--bacterial infection
-bactroban (mupirocin)
-antifungal medications not effective
child presenting with multiple infections - aNSWER-treat with one medication that covers all
conditions to increase compliance
treatment for opioid induced constipation and its method of action - aNSWER-methylnaltrexone
has limited ability to cross blood brain barrier allowing the ability to antagonize peripheral μ-
opioid receptors- does not affect opioid effectiveness
first line treatment for patients with h.pylori - aNSWER-triple therapy
-PPI, clarithromycin, and amoxicillin for 14 days
glycogenesis - aNSWER-storing of excess glucose for body to use at a later time
